Home › Trial NCT04537156
Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
- Trial IDNCT04537156
- StatusActive Not Recruiting
- PhasePhase 3
- Study typeInterventional
- SponsorXiamen University
- Enrollment9327
- Start date2020-09-05
- ConditionsCervical Intraepithelial Neoplasia · Cervical Cancer · Condylomata Acuminata
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.